Combined hormonal contraception (oral)
Drug Safety Update
April 2008: Hormonal contraceptives: cervical cancer
February 2014: Combined hormonal contraceptives and venous thromboembolism: review confirms risk is small
March 2014: Combined hormonal contraceptives: risk of venous thromboembolism
March 2014: St John’s wort: interaction with hormonal contraceptives, including implants
- Low strength preparations (containing ethinylestradiol 20 micrograms)
- Standard strength preparations (containing ethinylestradiol 30-35 micrograms)
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary